Fast Company Names egnite, Inc. One of Its Most Innovative Companies in 2024

Fast Company Names egnite, Inc. One of Its Most Innovative Companies in 2024

ALISO VIEJO, Calif. – March 19, 2024 Fast Company, the world’s leading progressive business media brand, announced egnite, Inc. as one of the World’s Most Innovative Companies in their 2024 ranking. egnite, a leading digital health company specializing in artificial intelligence solutions to advance cardiovascular care, stands at the forefront of innovation in the healthcare sector.

The 2024 list showcases businesses pioneering advancements within their industries, setting new standards for innovation and paving the way for future breakthroughs. Among these trailblazers, egnite is recognized for its significant contributions to improving healthcare efficiency and patient outcomes.

In a world where heart disease remains a leading cause of mortality, with over 800,000 annual deaths in the U.S. alone, egnite’s artificial intelligence (A.I.) solutions help physicians reduce variability in care to ensure patients get the right treatment at the right time. In 2023, the company launched several new artificial intelligence technologies focused on helping physicians identify patients with risk for stroke, heart failure, and heart valve disease. Today, clinicians use egnite’s technology to screen and monitor patients, ensuring significant disease is quickly detected and treated before it’s too late.

“Gaps in care may unintentionally delay care for patients with life-threatening cardiovascular diseases. Artificial Intelligence technologies hold the potential to dramatically improve patient care and alleviate burdens on healthcare providers nationwide. Through these innovative solutions, we’re enabling providers to practice top-of-license care and ensure more patients are receiving life-saving therapy,” says Kahla Verhoef, chief product officer of egnite.  

To date, egnite’s technology:

  • Helps providers save 2 lives a day
  • Improves workflow efficiencies by up to 55%.¹
  • Increased life-saving treatment rates by 25%²

egnite’s commitment to advancing healthcare through innovative technologies underscores its position as a leader in the digital health space. As the company continues to leverage its technology to help improve patient care, it remains dedicated to shaping the future of cardiovascular health.

About egnite, Inc.

egnite is a visionary digital health company committed to advancing the health of our society through innovative cardiovascular solutions. egnite uses AI-driven algorithms and big data to produce business intelligence for healthcare, elevating the role of data in critical decisions. The company, based in Aliso Viejo, California, partners with leading hospitals and life sciences organizations to transform care delivery for cardiovascular patients. For more information, visit www.egnitehealth.com.

References

  1. Compared to traditional screening methods
  2. Represents median growth from 17 CardioCare sites with baseline data one year after implementing the CardioCare platform.

Related Articles

Press

egnite, Inc. and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference

egnite, Inc., a leading digital health company specializing in cardiovascular care, today announced the addition of two distinguished physicians, Vinod H. Thourani, MD and Nicholas Amoroso, MD to its Medical Advisory Board. Their wealth of expertise in cardiovascular care and dedication to innovation will significantly contribute to egnite’s mission to improve cardiovascular patient care nationwide.

Real-World Evidence

Mortality Burden for Patients with Untreated Aortic Regurgitation

“This research underscores the poor outcomes for patients with moderate AR who exhibit cardiac damage, stressing the need to monitor for distinct characteristics in this population. These insights may also prompt a reassessment of our management strategies and suggest a shift in our approach to intensified follow-up for both moderate

Press

egnite, Inc. Announces the Appointment of Vinod Thourani and Nicholas Amoroso to Its Medical Advisory Board

egnite, Inc., a leading digital health company specializing in cardiovascular care, today announced the addition of two distinguished physicians, Vinod H. Thourani, MD and Nicholas Amoroso, MD to its Medical Advisory Board. Their wealth of expertise in cardiovascular care and dedication to innovation will significantly contribute to egnite’s mission to improve cardiovascular patient care nationwide.